XML 89 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]  
Revenue $ 357,880
Net income 204,987
Net income attributable to Innoviva stockholders $ 214,390